Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

Clinical and OCT Findings in Chronic Solar Retinopathy
SHAILEEN PARIKH, MS, DO, FMRF
Annual Meeting Talks
2018
Parameters Affecting Postoperative Success of Surgery for Stage 4a/4b ROP
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2018
Inflammation After Aflibercept Injection in Association With a Specific Brand of Syringe That Releases Silicone Oil Droplets A Case-Control Study
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more